Analysts Viewpoint
RLMD shares expected to outperform in the next 12 months
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Relmada Therapeutics Inc’s recently made public that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $86735.0 on
Relmada Therapeutics Inc’s recently made public that its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $86735.0 on
In a filing, Relmada Therapeutics Inc revealed its Chief Executive Officer TRAVERSA SERGIO acquired Company’s shares for reported $86735.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Relmada Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Kelly Paul Edward acquired Company’s shares for reported $86060.0